Aethlon Medical (NASDAQ:AEMD) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research report released on Wednesday morning. The brokerage issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright restated a “buy” rating and issued a $7.00 target price on shares of Aethlon Medical in a research note on Friday, November 15th.

Aethlon Medical Price Performance

Shares of NASDAQ:AEMD opened at $0.58 on Wednesday. The business’s fifty day moving average price is $0.40 and its two-hundred day moving average price is $0.42. Aethlon Medical has a fifty-two week low of $0.24 and a fifty-two week high of $2.35. The stock has a market capitalization of $8.10 million, a price-to-earnings ratio of -0.21 and a beta of 1.79.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.